• 14C custom radiolabelling, specialising in 14C GMP API, for metabolism, environmental fate and human ADME studies.
  • Structural elucidation and impurity profiling; synthesis and GLP characterisation of process impurity, degradation products and metabolites.
  • Unique peptidyl prolyl isomerase (PPIase) screening platform including binding and functional assays.
  • Providing integrated drug discovery services to pharma, biotechnology companies and academic institutions.

Drug Discovery

Providing integrated drug discovery services to pharma, biotechnology companies and academic institutions.

Read more

Medicinal Chemistry
Assay Development and Screening
Target Class and Disease Expertise

Radiolabelling

14C custom radiolabelling for metabolism, environmental fate and specialising in 14C GMP API for human ADME studies.

Read more

14C Custom Synthesis
14C GMP Radiolabelled API for Clinical Trials
GLP Analytics

Chemistry & Analytics

Structural elucidation and impurity profiling; synthesis and GLP characterisation of process impurity, degradation products and metabolites.

Read more

Custom Synthesis
Crop Science Expertise
GLP anaysis including GLP NMR

News

29 February 2016
Selcia Celebrates Anniversary of the Discovery of Carbon-14
26 January 2016
In a new article in Drug Target Review, Dr. Hans Fliri highlights the potential of cyclophilin...

Upcoming Events

4 May 2016 to 6 May 2016
Selcia is attending Mitochondrial Medicine at the Wellcome Genome Campus, Hinxton, Cambridge, UK.
22 May 2016 to 26 May 2016
Discuss radiolabelling with our technical expert at the SETAC Europe Annual Meeting in Nantes

Selcia Tweets